Does endotracheal suction prevent meconium aspiration syndrome?
ACOG update: Committee Opinion 689, March 2017
Please note that as of March 2017, ACOG has released guidance that is in accordance with AAP and AHA:
Infants with meconium-stained amniotic fluid, regardless of whether they are vigorous or not, should no longer routinely receive intrapartum suctioning. However, meconium-stained amniotic fluid is a condition that requires the notification and availability of an appropriately credentialed team with full resuscitation skills, including endotracheal intubation.
Resuscitation should follow the same principles for infants with meconium-stained fluid as for those with clear fluid
The study described below provided strong evidence in support of these guidelines.
When considering whether or not to perform endotracheal suction on a nonvigorous newborn infant in the setting of meconium stained fluid, a randomized controlled trial (RCT) found the following:
There were no significant differences between suctioned and non-suctioned newborns for the following outcomes:
Meconium aspiration syndrome, its severity and complications
Neurodevelopmental outcomes at 9 months of age
Using an RCT design, Chettri and colleagues (J Pediatr. 2015) sought to determine if endotracheal suction actually prevents meconium aspiration syndrome and its related complications.
Routine endotracheal suction does not appear to alter outcome with respect to meconium aspiration syndrome in the setting of meconium stained fluid and poor muscle tone and inadequate breathing efforts
Routine endotracheal suction is not recommended by ACOG, AAP and the AHA Guidelines due to limited evidence of benefit
Please log in to access ObGFirst and the 2T US Atlas
Media - Internet
Computer System Requirements
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan